Home> Products> telmisartan 80 mg amlodipine 5 mg bp control

{ "products": [ { "_id": "69e9f8f5051af90911258c1b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "nebivolol 5mg cilnidipine 10mg", "description": "Nebivolol 5mg + Cilnidipine 10mg Tablets—Complete Guide\nA fixed-dose combination antihypertensive for effective blood pressure control. Understand how it works, who it's for, dosage, and safety before you buy.\n\nDrug Class\nBeta-blocker + Calcium Channel Blocker\nStrength\nNebivolol 5mg / Cilnidipine 10mg\nRoute\nOral (tablet)\nSchedule\nRx Only\nWhat is this combination?\nUnderstanding nebivolol 5mg + cilnidipine 10mg\nNebivolol 5mg + cilnidipine 10mg is a fixed-dose combination tablet prescribed for the management of hypertension (high blood pressure) in adults. It pairs two complementary mechanisms into one convenient pill, making it a popular choice when single-drug therapy proves insufficient for adequate blood pressure control.\n\nThis combination is widely preferred by cardiologists when patients need better BP reduction with fewer pills, improved tolerability, and protection of vital organs such as the heart and kidneys. If your doctor has prescribed this tablet, you're likely being treated for stage 1 or stage 2 hypertension, with or without associated cardiovascular risk factors.\n\nThis is not an over-the-counter product. Always use nebivolol + cilnidipine tablets only under the supervision of a licensed physician. Self-medication or dose changes without medical advice can be dangerous.\nHow it works\nMechanism of action — dual-pathway blood pressure control\nThe effectiveness of this combination lies in how its two active ingredients target blood pressure through different pathways simultaneously:\n\nNebivolol 5mg\nA third-generation cardioselective beta-1 blocker. It slows the heart rate, reduces the force of cardiac contraction, and lowers cardiac output. Uniquely, nebivolol also releases nitric oxide, causing blood vessel relaxation — a property not seen in older beta-blockers. This makes it better tolerated and less likely to cause sexual dysfunction or cold extremities.\nCilnidipine 10mg\nAn N/L-type calcium channel blocker. Unlike conventional CCBs (e.g., amlodipine), cilnidipine blocks both L-type and N-type calcium channels. N-type blockade in the sympathetic nervous system reduces norepinephrine release, leading to smoother, more sustained BP reduction with significantly less ankle swelling — a common complaint with older CCBs.\nTogether, these agents provide additive antihypertensive effect while offsetting each other's side effects. Nebivolol reduces tachycardia that CCBs can sometimes cause, while cilnidipine's vasodilatory effect complements nebivolol's cardiac output reduction.\n\nIndications\nWho is Nebivolol 5 mg and Cilnidipine 10 mg prescribed for?\nThis combination is indicated for adults with hypertension who are not adequately controlled on monotherapy. It is especially suited for patients who have:\n\nCondition:\tWhy this combination is preferred\nHypertension with high heart rate\tNebivolol slows heart rate while cilnidipine controls peripheral resistance\nHypertension with diabetes\tMetabolically neutral; does not worsen glucose tolerance or lipid profile\nHypertension with CKD / proteinuria:\tCilnidipine's N-type blockade reduces glomerular pressure and protein leakage\nHypertension with coronary artery disease\tNebivolol provides cardioprotection and anti-anginal effect\nAmlodipine-related ankle edema\tSwitching to cilnidipine substantially reduces pedal edema due to N-type blockade\nUncontrolled BP on single antihypertensive\tCombination adds complementary mechanisms without increasing pill burden\n\nosage & Administration\nHow to take nebivolol 5 mg + cilnidipine 10mg\nThe standard recommended dose is one tablet once daily, preferably at the same time each day — most commonly in the morning with or without food. Your physician may adjust the dose based on your blood pressure response and individual tolerability.\n\nDo not crush, chew, or split the tablet unless your doctor advises. If you miss a dose, take it as soon as you remember, but skip it if it is almost time for the next dose. Never double up on doses. Swallowing the tablet whole with water is the preferred method of administration.\n\nDo not stop taking this medication abruptly. Sudden discontinuation of nebivolol (a beta-blocker) can trigger rebound hypertension or even angina in patients with underlying coronary disease. Always taper under medical guidance.\n\nCommon and serious side effects to know\nLike all medicines, nebivolol + cilnidipine can cause side effects, though not everyone experiences them. Knowing what to watch for helps you respond promptly.\n\nSide effect\tFrequency\tWhat to do\nHeadache, dizziness\tCommon (early phase)\tUsually resolves in 1–2 weeks; avoid sudden posture changes\nFatigue, tiredness\tCommon\tMonitor; often improves after dose adjustment\nAnkle swelling (pedal edema)\tLess common than with amlodipine\tReport if worsening; may require dose review\nBradycardia (slow heart rate)\tUncommon\tSeek medical advice if heart rate <50 bpm\nNausea, stomach upset\tUncommon\tTake after meals to minimise\nBronchospasm\tRare\tStop immediately; seek emergency care if breathlessness\nSevere hypotension\tRare\tEmergency — seek immediate medical attention.\n\nWhen should this combination not be used?\nImportant safety information\nThis tablet is contraindicated in: cardiogenic shock, decompensated heart failure, severe bradycardia (<60 bpm), sick sinus syndrome, second- or third-degree AV block (without pacemaker), severe hepatic impairment, known hypersensitivity to nebivolol or cilnidipine, pregnancy, and breastfeeding.\n\nUse with caution in patients with asthma or COPD (nebivolol has some beta-2 activity at higher doses), peripheral vascular disease, diabetes mellitus (may mask hypoglycemic symptoms), and in elderly patients prone to falls due to postural hypotension.\n\nAlways inform your doctor of all medications you are currently taking. Clinically significant interactions exist with other antihypertensives, NSAIDs, digoxin, antidiabetic agents, and CYP2D6 inhibitors (e.g., fluoxetine, paroxetine), which can raise nebivolol plasma levels.\n\n\n\n\n", "price": 305.0, "discountamount": 91.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2389, "imageuri": "https://productimages.withfloats.com/actual/69e9f8f745652456a0f3a497.png", "tileimageuri": "https://productimages.withfloats.com/tile/69e9f8f745652456a0f3a497.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-23T10:48:21.085Z", "updatedon": "2026-04-29T05:46:26.285Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nebivolol-5mg-cilnidipine-10mg/2389", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NEBIVALVE CILNL 5/10", "category": "CARDIOLOGYRANGE", "tags": [ "nebivolol 5mg cilnidipine 10mg", "What is nebivolol 5mg and cilnidipine 10 mg used for?", "nebivolol cilnidipine", "nebivolol cilnidipine tab", "nebivolol cilnidipine uses", "nebivolol 5mg cilnidipine 10mg price", "nebivolol 5mg cilnidipine 10mg price in india", "nebivolol cilnidipine", "nebivolol 5mg cilnidipine 10mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d8537a81222f3e958917cc", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Telmisartan IP (80 mg) , Chlorthalidone IP (12.5mg)", "description": "Telmistrum CH 80/12.5 \nTelmisartan IP (80 mg) , Chlorthalidone IP (12.5mg)\nTelmistrum CH 80/12.5 combines Telmisartan (80 mg) and Chlorthalidone (12.5 mg), a potent duo for managing hypertension. This medication integrates an angiotensin II receptor blocker with a diuretic to effectively control blood pressure.\n\n \nHow Does It Work?\n \n\nTelmisartan: Blocks angiotensin II, relaxing blood vessels.\nChlorthalidone: Removes excess salt and water, reducing blood pressure.\n \nUses Of\n \n\nTreats high blood pressure.\nReduces risk of stroke and heart attack.\n \nWhat Is\n \n\nTelmisartan: An antihypertensive agent.\nChlorthalidone: A diuretic enhancing blood pressure control.\n \nSide Effects\n \n\nDizziness\nFatigue\nDehydration\n \nSafety Information\n \n\nMonitor kidney function.\nAvoid potassium supplements unless prescribed.\nConsult a doctor if pregnant or breastfeeding.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 290.0, "discountamount": 87.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "potent duo", "excess salt", "Side Effects", "heart attack", "Telmistrum CH", "blood vessels", "Telmisartan IP", "kidney function", "Chlorthalidone IP", "Dizziness Fatigue", "high blood pressure", "potassium supplements", "antihypertensive agent", "Dehydration Safety Information", "angiotensin II receptor blocker", "diuretic enhancing blood pressure control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1968, "imageuri": "https://productimages.withfloats.com/actual/66d8537b2313473aa80ef148.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d8537b2313473aa80ef148.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-04T12:32:58.221Z", "updatedon": "2026-03-14T07:23:01.686Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//telmisartan-ip-80-mg-chlorthalidone-ip-12-5mg-/1968", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Telmistrum CH 80/12.5 ", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66d83ad4ed345980e0fca5c5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Voglibose 0.3mg, Metformin 500mg, Gliclazide 80mg", "description": "GLICLAGLAZE TRIO 0.3 \nVoglibose (0.3mg), Metformin (500mg), Gliclazide (80mg)\nGLICLAGLAZE TRIO 0.3 is a powerful combination medication designed to manage and control type 2 diabetes. It is formulated with three active ingredients: Voglibose, Metformin, and Gliclazide. This unique combination helps to regulate blood sugar levels effectively, providing a comprehensive approach to diabetes management. GLICLAGLAZE TRIO 0.3 is particularly useful for patients who require a multifaceted treatment strategy to keep their blood glucose levels in check.\n\nKey Benefits:\nEffective Blood Sugar Control: The combination of Voglibose, Metformin, and Gliclazide offers a synergistic effect, providing comprehensive control over blood sugar levels.\nPrevents Post-Meal Sugar Spikes: Voglibose helps in delaying glucose absorption, reducing the risk of hyperglycemia after meals.\nImproved Insulin Sensitivity: Metformin enhances the body's response to insulin, ensuring better glucose management.\nEnhanced Insulin Secretion: Gliclazide helps in stimulating insulin release from the pancreas, making it easier to maintain stable blood sugar levels.\nHow Does It Work?\nGLICLAGLAZE TRIO 0.3 works through a multi-pronged approach to manage diabetes. Voglibose slows down the absorption of carbohydrates in the gut, which helps to prevent rapid increases in blood sugar levels after meals. Metformin reduces the liver's glucose production and improves insulin sensitivity, ensuring better glucose uptake and utilization. Gliclazide stimulates the pancreas to release insulin, aiding in the reduction of blood glucose levels.\nDirections for Use:\nTake GLICLAGLAZE TRIO 0.3 as prescribed by your healthcare provider. It is typically taken before meals to maximize its effectiveness in controlling postprandial blood sugar spikes. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Your doctor will determine the appropriate dosage and frequency based on your individual health needs.\nSide Effects:\nLike all medications, GLICLAGLAZE TRIO 0.3 may cause some side effects. Common side effects include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. Hypoglycemia (low blood sugar) may occur, especially if you skip meals or engage in intense physical activity. Other possible side effects include dizziness, headache, and fatigue. If you experience any severe side effects or allergic reactions, seek medical attention immediately.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 173.44, "discountamount": 52.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Key Benefits", "abdominal pain", "glucose uptake", "type 2 diabetes", "rapid increases", "insulin release", "low blood sugar", "GLICLAGLAZE TRIO", "medical attention", "glucose absorption", "allergic reactions", "appropriate dosage", "synergistic effect", "unique combination", "glucose production", "glucose management", "diabetes management", "healthcare provider", "severe side effects", "Common side effects", "blood glucose levels", "comprehensive control", "multi-pronged approach", "comprehensive approach", "Post-Meal Sugar Spikes", "individual health needs", "three active ingredients", "intense physical activity", "stable blood sugar levels", "Enhanced Insulin Secretion", "Other possible side effects", "Improved Insulin Sensitivity", "gastrointestinal disturbances", "Effective Blood Sugar Control", "powerful combination medication", "multifaceted treatment strategy", "postprandial blood sugar spikes" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1962, "imageuri": "https://productimages.withfloats.com/actual/66d83afac7293b3595ec4ea6.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/66d83afac7293b3595ec4ea6.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-04T10:47:48.369Z", "updatedon": "2026-05-14T07:47:00.105Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//voglibose-0-3mg-metformin-500mg-gliclazide-80mg/1962", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE TRIO 0.3", "category": "DIABETIC RANGE", "tags": [ "Voglibose 0.3mg,", "Metformin 500mg", "Gliclazide 80mg", "voglibose metformin gliclazide tablet", "voglibose 0.3 metformin 500 gliclazide 80", "voglibose metformin gliclazide combination", "triple drug diabetes tablet voglibose", "voglibose gliclazide metformin tablet", "voglibose 0.3 mg metformin 500 mg gliclazide 80 mg", "voglibose metformin gliclazide fixed dose combination", "voglibose 0.3 mg triple combination tablet", "metformin 500 voglibose gliclazide tablet", "gliclazide 80 metformin voglibose tablet", "voglibose metformin gliclazide tablet for type 2 diabetes", "triple combination tablet for diabetes", "voglibose metformin gliclazide for blood sugar control", "voglibose metformin gliclazide uses", "how to take voglibose metformin gliclazide tablet", "voglibose metformin gliclazide tablet price", "voglibose metformin gliclazide manufacturer", "voglibose metformin gliclazide supplier" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665ef5bda743fd235821deeb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "gliclazide 80 mg metformin 500 mg", "description": "GLICLAGLAZE M 80 \ngliclazide (80 mg), metformin (500 mg)\nIntroduction\nGLICLAGLAZE M 80 is a specialized medication formulated for individuals diagnosed with Type 2 diabetes, aiming to enhance blood sugar regulation. This oral medication combines Gliclazide (80 mg) with Metformin (500 mg), two effective antidiabetic agents that provide a synergistic effect to control high blood sugar.\n\nMechanism of Action\n\nGliclazide (80 mg): Belonging to the sulfonylurea class, gliclazide works by increasing insulin secretion from the pancreatic beta cells. It promotes a decrease in blood glucose levels and enhances the action of insulin in the body. Additionally, Gliclazide improves blood flow and has protective effects against the vascular complications of diabetes.\nMetformin (500 mg): Metformin reduces hepatic glucose production and improves insulin sensitivity by enhancing peripheral glucose uptake, particularly in muscle cells. This action helps lower blood glucose levels without the risk of inducing hypoglycemia and is associated with a potential reduction in body weight.\nBenefits\nGLICLAGLAZE M 80 offers a robust approach to managing Type 2 diabetes by targeting different aspects of the disease. The combination of Gliclazide and Metformin in this medication helps to control blood sugar more effectively than either component alone, potentially lowering the patient's risk of diabetes-related complications.\n\nDosage and Administration\n\nDosage: The starting dose should be adjusted based on the patient’s previous medication regimen, effectiveness, and tolerability. Dose adjustments should be made based on glycemic control, as assessed by regular monitoring of blood glucose levels.\nAdministration: It is recommended to take GLICLAGLAZE M 80 with meals to maximize drug absorption and minimize potential gastrointestinal side effects.\nSide Effects\nPotential side effects of GLICLAGLAZE M 80 include gastrointestinal symptoms like nausea and diarrhea, which usually improve over time. The risk of hypoglycemia exists but is moderated by the inclusion of metformin.\n\nConclusion\nGLICLAGLAZE M 80 represents an effective treatment solution for managing Type 2 diabetes, combining two powerful antidiabetic agents to improve glycemic control and reduce the risk of diabetes complications. Patients should maintain regular consultations with their healthcare provider to tailor their treatment plan according to their specific needs, ensuring the best possible outcomes in diabetes management.\nFor further information:\nEMAIL: info@sterispharma.com / contact@sterispharma.com \n Order Now\n\n\n\n\n\n\n", "price": 137.0, "discountamount": 41.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "risk", "time", "Order", "meals", "EMAIL", "nausea", "500 mg", "Action", "patient", "disease", "diarrhea", "Benefits", "decrease", "Mechanism", "Metformin", "component", "inclusion", "Conclusion", "blood flow", "gliclazide", "individuals", "information", "body weight", "combination", "Introduction", "muscle cells", "tolerability", "sterispharma", "hypoglycemia", "sterisonline", "starting dose", "effectiveness", "CALL/WHATSAPP", "GLICLAGLAZE M", "treatment plan", "specific needs", "Type 2 diabetes", "oral medication", "robust approach", "drug absorption", "high blood sugar", "Dose adjustments", "glycemic control", "different aspects", "insulin secretion", "regular monitoring", "sulfonylurea class", "synergistic effect", "protective effects", "healthcare provider", "insulin sensitivity", "potential reduction", "diabetes management", "blood glucose levels", "regular consultations", "pancreatic beta cells", "Administration Dosage", "best possible outcomes", "blood sugar regulation", "Potential side effects", "specialized medication", "diabetes complications", "vascular complications", "gastrointestinal symptoms", "peripheral glucose uptake", "hepatic glucose production", "previous medication regimen", "effective treatment solution", "diabetes-related complications", "two powerful antidiabetic agents", "two effective antidiabetic agents", "potential gastrointestinal side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1287, "imageuri": "https://productimages.withfloats.com/actual/665ef5c0ca75628a5853ff45.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef5c0ca75628a5853ff45.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:08:45.584Z", "updatedon": "2026-03-13T05:37:48.45Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gliclazide-80-mg-metformin-500-mg/1287", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE M 80 ", "category": "DIABETIC RANGE", "tags": [ "gliclazide 80 mg metformin 500 mg tablet uses", "gliclazide 80 mg metformin 500 mg dosage for diabetes", "gliclazide metformin 80 mg 500 mg side effects", "gliclazide metformin 80 mg 500 mg how it works" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "69cf8589ee7201fd096ce0b4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Atorvastatin 80 mg and Ezetimibe 10 mg", "description": "Introduction\n\nATOVASTRIN EZ 80/10 is a powerful combination therapy formulated with Atorvastatin 80 mg and Ezetimibe 10 mg, designed to provide comprehensive management of high cholesterol levels. This dual-action medication is widely prescribed for patients who require aggressive lipid-lowering therapy, especially those at high risk of cardiovascular diseases such as heart attack and stroke.\n\nIn today’s fast-paced lifestyle, unhealthy eating habits, stress, and lack of physical activity have significantly increased the prevalence of high cholesterol. If left untreated, it can lead to serious complications including atherosclerosis (narrowing of arteries), heart disease, and other life-threatening conditions. ATOVASTRIN EZ 80/10 offers an advanced and effective solution to control cholesterol levels and improve overall heart health.\n\nWhat is ATOVASTRIN EZ 80/10?\n\nATOVASTRIN EZ 80/10 is a fixed-dose combination of:\n\nAtorvastatin 80 mg – A statin that reduces cholesterol production in the liver\nEzetimibe 10 mg – A cholesterol absorption inhibitor that reduces dietary cholesterol uptake from the intestine\n\nThis combination works synergistically to lower both endogenous (produced by the body) and exogenous (dietary) cholesterol, providing superior lipid control compared to monotherapy.\n\nHow ATOVASTRIN EZ 80/10 Works\n\nATOVASTRIN EZ 80/10 works through a dual mechanism:\n\n1. Reduction of Cholesterol Production\n\nAtorvastatin inhibits the HMG-CoA reductase enzyme in the liver, which is responsible for cholesterol synthesis. This leads to a significant reduction in LDL (bad cholesterol).\n\n2. Decreased Cholesterol Absorption\n\nEzetimibe blocks the absorption of cholesterol from the small intestine, reducing the amount of cholesterol entering the bloodstream.\n\n3. Improved Lipid Profile\n\nThe combination helps in:\n\nLowering LDL cholesterol\nReducing total cholesterol\nDecreasing triglycerides\nIncreasing HDL (good cholesterol)\n4. Prevention of Plaque Formation\n\nBy lowering cholesterol levels, it helps prevent plaque buildup in arteries, reducing the risk of cardiovascular diseases.\n\nUses of ATOVASTRIN EZ 80/10\n\nATOVASTRIN EZ 80/10 is used for:\n\nTreatment of high cholesterol (hyperlipidemia)\nManagement of mixed dyslipidemia\nPrevention of heart attack and stroke\nReduction of cardiovascular risk in high-risk patients\nTreatment of patients not adequately controlled on statin therapy alone\nKey Benefits of ATOVASTRIN EZ 80/10\n1. Powerful Dual Action\n\nCombines two effective mechanisms for superior cholesterol reduction.\n\n2. Significant LDL Reduction\n\nHelps in aggressively lowering bad cholesterol levels.\n\n3. Cardiovascular Protection\n\nReduces the risk of heart attack, stroke, and other heart-related complications.\n\n4. Improved Overall Lipid Profile\n\nBalances cholesterol levels by lowering LDL and increasing HDL.\n\n5. Convenient Combination Therapy\n\nEliminates the need for multiple medications, improving patient compliance.\n\n6. Suitable for High-Risk Patients\n\nIdeal for individuals with diabetes, hypertension, or existing heart conditions.\n\nHow to Use ATOVASTRIN EZ 80/10\nTake ATOVASTRIN EZ 80/10 as prescribed by your doctor\nUsually taken once daily, with or without food\nSwallow the tablet whole with water\nFollow a cholesterol-lowering diet and healthy lifestyle for best results\nRegular lipid profile monitoring is recommended\nSide Effects of ATOVASTRIN EZ 80/10\n\nLike all medications, ATOVASTRIN EZ 80/10 may cause side effects:\n\nCommon Side Effects:\nHeadache\nMuscle pain (myalgia)\nAbdominal discomfort\nNausea\nLess Common Side Effects:\nElevated liver enzymes\nFatigue\nDiarrhea\nSerious Side Effects (Rare):\nSevere muscle breakdown (rhabdomyolysis)\nLiver dysfunction\nAllergic reactions\nPrecautions and Warnings\nAvoid alcohol consumption as it may increase liver-related risks\nNot recommended during pregnancy and breastfeeding\nInform your doctor if you have liver or kidney disease\nRegular monitoring of liver function tests is required\nInform your doctor about all medications you are taking to avoid interactions\nWho Should Use ATOVASTRIN EZ 80/10?\n\nThis medication is ideal for:\n\nPatients with high cholesterol levels\nIndividuals at high risk of cardiovascular diseases\nPatients not responding to statin therapy alone\nPeople with diabetes or hypertension needing lipid control\nStorage Instructions\nStore in a cool and dry place\nKeep away from direct sunlight\nKeep out of reach of children\nWhy Choose ATOVASTRIN EZ 80/10?\n\nATOVASTRIN EZ 80/10 stands out because of:\n\nAdvanced dual-action formulation\nProven clinical effectiveness\nConvenient once-daily dosage\nComprehensive lipid management\nTrusted by healthcare professionals\nConclusion\n\nATOVASTRIN EZ 80/10 (Atorvastatin 80 mg + Ezetimibe 10 mg) is a highly effective and advanced therapy for managing high cholesterol and reducing cardiovascular risks. Its dual-action mechanism ensures maximum cholesterol reduction by targeting both production and absorption pathways.", "price": 580.0, "discountamount": 174.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2366, "imageuri": "https://productimages.withfloats.com/actual/69cf8591d572ad80ed9cf5b4.png", "tileimageuri": "https://productimages.withfloats.com/tile/69cf8591d572ad80ed9cf5b4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-03T09:16:57.37Z", "updatedon": "2026-04-03T09:16:57.37Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//atorvastatin-80-mg-and-ezetimibe-10-mg/2366", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ATOVASTRIN EZ 80/10", "category": "CARDIOLOGYRANGE", "tags": [ "atorvastatin 80 mg and ezetimibe 10 mg tablets uses", "atorvastatin 80 mg ezetimibe 10 mg combination benefits", "atorvastatin ezetimibe 80/10 dosage and uses", "atorvastatin 80 mg ezetimibe 10 mg mechanism of action", "buy atorvastatin 80 mg ezetimibe 10 mg tablets online", "atorvastatin 80/10 tablets wholesale price india", "atorvastatin ezetimibe tablets b2b supplier", "where to buy atorvastatin ezetimibe tablets in india", "atorvastatin ezetimibe tablets best price", "fast delivery atorvastatin ezetimibe bulk order" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694919f0de5d3e57a93413a8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "elagolix 150mg tablet", "description": "Eligolux 150 delivers 150mg of elagolix per tablet, formulated as an oral, once-daily option in convenient packs for ongoing therapy. As a non-peptide GnRH receptor antagonist, it selectively suppresses pituitary gonadotropins, reducing ovarian estrogen production without the flare effect of agonists. Ideal for patients with milder symptoms or those prioritizing bone health, this dose minimizes hypoestrogenic risks while targeting endometriotic pain.\n\nTake Eligolux 150 whole with water, with or without food, preferably at the same time daily. Storage requires a cool, dry environment below 30°C, away from children and moisture. Steris Healthcare ensures GMP-compliant manufacturing, making it accessible across India for endometriosis care.\n\nPrimary Uses and Indications\nEligolux 150 primarily treats moderate endometriosis-associated pain, including dysmenorrhea, chronic pelvic discomfort, and dyspareunia. Endometriosis impacts 10% of reproductive-age women, causing ectopic endometrial growth that triggers inflammation and scarring; elagolix 150mg curbs estrogen-driven progression.\n​\nPrescribed when NSAIDs or combined pills prove inadequate, it excels in non-severe cases, allowing prolonged use. Emerging evidence supports its role in heavy menstrual bleeding from fibroids, though primary approval focuses on pain relief. Start therapy within the first week of menses for optimal synchronization.\n​\nMechanism of Action\nElagolix in Eligolux 150 competitively binds GnRH receptors, dose-dependently inhibiting LH/FSH release. This lowers estradiol by 40-60%—less aggressive than 200mg—halting endometrial tissue proliferation outside the uterus. Peak levels hit in 1 hour, with a 4-6 hour half-life supporting steady-state suppression on QD dosing.\n​\nUnlike agonists, no initial hormone surge occurs, preventing worsened pain. Partial estrogen reduction preserves some bone-protective effects, differentiating it from deeper suppression therapies.\n\nKey Benefits\nEligolux 150 shines in clinical responsiveness: phase 3 trials showed 32% dysmenorrhea resolution versus 20% placebo at 6 months, with 50% pain score drops. Quality-of-life gains include better work attendance, sleep, and relationships, per EQ-5D assessments.\n​\nExtended 24-month approval suits long-term control, with amenorrhea in 40-50% of users reducing bleeding volume by 70%. Oral ease beats injectables, enhancing adherence at 85% in studies. Lower BMD impact (0.5-1% loss/year) allows safer continuation versus higher doses.\n\nBenefit\tTrial Data\tPatient Impact\nPain Reduction\t32-50% dysmenorrhea-free \n​\tDaily activity restoration\nBleeding Control\t70% volume drop \n​\tAnemia prevention\nLong-Term Use:\tUp to 24 months \n​\tSustained relief\nQoL Improvement\tEQ-5D gains \n​\tEmotional well-being\nPotential Side Effects\nVasomotor symptoms dominate: hot flashes (20-30%), headaches (17%), and night sweats (10-15%) emerge early but fade. Nausea (8%), insomnia (7%), and mild depression (5%) affect minorities, with a 70% event rate mostly grade 1.\n​\nBMD decline averages -0.9% at the spine after 12 months, monitored via DEXA. Discontinuation hovers at 5-8%.\n\nSide Effect\tIncidence\tMitigation\nHot Flashes\t20-30% \n​\tVentilation, timing\nHeadache\t17% \n​\tAnalgesics\nBMD Loss\t0.9% \n​\tSupplements, scans\nMood Shifts\t5% \n​\tMonitoring\nSerious Risks and Management\nSuicidality (0.1-0.5%) demands baseline psych screening; halt if worsening. Liver enzymes rise in 1%, requiring LFTs at 3/6 months. Rare anaphylaxis or thromboembolism prompts immediate cessation. Avoid in osteoporosis or smokers >35.\n​\n\nDosage Guidelines\n150 mg once daily for up to 24 months in normal/mild liver function; limit to 6 months in moderate impairment (Child-Pugh B). No titration needed; miss a dose? Resume the next day, no doubling. Pair with 1 g calcium/800 IU vitamin D daily.\n​\n\nPrecautions and Contraindications\nPregnancy category X: mandates non-hormonal birth control during and 1 week post-therapy. Screen hepatic/renal function; avoid severe cases. CYP3A interactions (e.g., rifampin reduces efficacy) need dose review. Breastfeeding is contraindicated.\n​\nClinical Evidence and Efficacy\nElaris trials (n=1,689) confirmed superiority: co-primary endpoints met with 75% responder rates for pain. 12-month extensions showed persistent efficacy and low rebound. Versus 200mg, 150mg balances tolerability for moderate pain.\n​\nConclusion\nEligolux 150 empowers women with moderate endometriosis pain through precise, extended hormonal modulation and proven outcomes. Regular physician oversight maximizes safety and efficacy.\n", "price": 700.0, "discountamount": 210.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2252, "imageuri": "https://productimages.withfloats.com/actual/694a2af01e4092f757d90bb5.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2af01e4092f757d90bb5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T10:14:08.773Z", "updatedon": "2026-03-26T05:59:45.544Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-150mg-tablet/2252", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 150", "category": "GYANECOLOGYRANGE", "tags": [ "elagolix 150mg tablet", "prioritizing bone health.", "endometriotic pain.", "endometrial tissue proliferation outside the uterus.", "Eligolux 150 empowers women with moderate endometriosis pain through precise.", "hormonal modulation and proven outcomes.", "gonadotropins.", "endometriotic pain." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6932959513286b8c66d8786f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Myoinositol 600mg + Metformin SR 500", "description": "OVOCYST M is a specialized sustained-release tablet combining Myoinositol 600mg and Metformin SR 500mg, primarily designed to address polycystic ovary syndrome (PCOS) and related metabolic issues in women. This formulation from Steris Healthcare Pvt Ltd targets insulin resistance, hormonal imbalances, and ovulatory dysfunction, making it a go-to option for restoring reproductive wellness. By improving insulin sensitivity and ovarian function, OVOCYST M supports regular cycles and fertility outcomes effectively.​\n\nProduct Composition and Mechanism\nOVOCYST M features Myoinositol 600mg, a natural insulin signaling mediator that enhances cellular health and oocyte quality in PCOS patients. Paired with Metformin SR 500mg, a sustained-release biguanide that lowers hepatic glucose production and boosts peripheral insulin uptake, this duo tackles root causes like hyperinsulinemia. The SR technology ensures gradual release, minimizing digestive upset while providing prolonged metabolic support throughout the day.​\n\nThis synergistic action restores ovulatory cycles by balancing hormones such as FSH and LH, reducing androgen excess common in PCOS. Women experiencing anovulation or irregular menses find OVOCYST M particularly beneficial as it promotes follicular development without aggressive interventions.​\n\nKey Uses of OVOCYST M\nOVOCYST M excels in managing PCOS symptoms, including irregular menstrual cycles and infertility linked to insulin resistance. Healthcare providers often prescribe it for hyperandrogenism, where elevated male hormones cause hirsutism or acne, alongside metabolic syndrome features like obesity.​\n\nSupports fertility treatments by improving egg quality and implantation rates in assisted reproduction.​\nAids weight management in PCOS by curbing insulin-driven fat accumulation.​\nRegulates blood sugar in prediabetic women with PCOS, preventing progression to type 2 diabetes.​\nTypically taken once or twice daily with meals, the dosage aligns with physician guidance for optimal results over 4-12 weeks.​\n\nMajor Benefits for PCOS and Beyond\nOne standout advantage of OVOCYST M is its ability to normalize ovulation, with studies showing improved cycle regularity in up to 70-80% of users. By enhancing insulin sensitivity, it reduces hyperinsulinemia, alleviating symptoms like fatigue and cravings that hinder daily life.​\n\nPromotes modest weight loss (2-5kg over months) through better metabolic control, boosting self-esteem and mobility.​\n\nEnhances fertility by maturing oocytes and lowering miscarriage risks in PCOS pregnancies.​\n\nLowers androgen levels, clearing skin issues and reducing unwanted hair growth for aesthetic and emotional relief.​\n\nLong-term use under supervision sustains these gains, fostering holistic health improvements like better energy and mood stability.​\n\nPotential Side Effects and Precautions\nWhile generally well-tolerated, OVOCYST M may cause mild gastrointestinal effects such as nausea, flatulence, or a metallic taste from Metformin. These often subside with time or food intake, thanks to the SR formulation's gentler profile.​\n\nRare but serious risks include lactic acidosis in those with kidney/liver issues, warranting avoidance in such cases. Precautions involve monitoring blood sugar, avoiding during acute illnesses, and consulting doctors if pregnant or breastfeeding.​\n\nCommon: Bloating or diarrhea, manageable by starting low dose.​\n\nConsult promptly for persistent vomiting or weakness.​\n\nConclusion\nOVOCYST M stands as a reliable, science-backed ally for women battling PCOS, insulin resistance, and fertility hurdles through its potent Myoinositol 600mg and Metformin SR 500mg blend. Delivering tangible benefits like restored cycles, weight control, and enhanced conception chances, it empowers proactive reproductive health management. Always pair with lifestyle tweaks like balanced diet and exercise for peak efficacy, and rely on professional oversight for safe, sustained results—transforming challenges into opportunities for vitality.", "price": 257.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2233, "imageuri": "https://productimages.withfloats.com/actual/693295fa395d93bf6f980d94.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/693295fa395d93bf6f980d94.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-05T08:19:33.812Z", "updatedon": "2026-03-26T06:02:58.674Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//myoinositol-600mg-metformin-sr-500/2233", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OVOCYST M", "category": "GYANECOLOGYRANGE", "tags": [ "Myoinositol 600mg and Metformin SR 500mg", "polycystic ovary syndrome (PCOS)", "OVOCYST M supports regular cycles and fertility" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "691b1c603e7435a75b8de28f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "lurasidone hydrochloride 80 mg | LURASINODE 80", "description": "LURASINODE 80 is a high-strength antipsychotic formulation containing Lurasidone Hydrochloride 80 mg, a well-established atypical antipsychotic medication used to treat serious mental health disorders. Lurasidone is known for its effectiveness in managing symptoms of schizophrenia and bipolar depression by balancing neurotransmitters in the brain, such as dopamine and serotonin. This helps improve mood, reduce hallucinations, and restore clear thinking. LURASINODE 80 is widely recommended by mental health professionals due to its strong therapeutic impact, lower risk of metabolic side effects, and excellent long-term tolerance. Designed for daily use, it supports emotional stability and improved functioning in individuals dealing with overwhelming mental health challenges.\n\nUses\n\nLURASINODE 80 is primarily prescribed for psychiatric conditions that require consistent brain chemical regulation. Its main uses include:\n\nTreatment of Schizophrenia: Helps reduce hallucinations, delusions, disorganized thinking, and emotional withdrawal.\n\nManagement of Bipolar Depression (Bipolar I Disorder): Used alone or with mood stabilizers to reduce severe depressive episodes.\n\nImprovement of Cognitive Function in Mental Disorders: Supports better focus, clarity, and goal-directed behavior.\n\nLong-term Maintenance Therapy: Helps prevent relapse and maintain mental well-being in chronic psychiatric conditions.\n\nThis powerful antipsychotic is beneficial for individuals requiring dependable and steady symptom control.\n\nBenefits\n\nThe 80 mg strength of Lurasidone in LURASIDONE 80 offers several key therapeutic benefits:\n\n1. Effective Symptom Control\n\nLurasidone targets dopamine and serotonin receptors, helping reduce hallucinations, mood swings, irritability, and psychotic symptoms.\n\n2. Lower Risk of Weight Gain and Metabolic Side Effects\n\nUnlike many other antipsychotics, Lurasidone has a favorable metabolic profile, making it suitable for long-term use.\n\n3. Enhances Cognitive Functioning\n\nPatients often experience improved attention, clearer thinking, and better decision-making skills.\n\n4. Supports Emotional Stability\n\nEffective in managing depressive symptoms associated with bipolar disorder, offering mood stabilization and improved emotional balance.\n\n5. Once-Daily Convenience\n\nThe single daily dose enhances treatment adherence, making it easier for patients to maintain a consistent routine.\n\nDosage\n\nThe usual recommended dosage of LURASINODE 80 is one tablet daily, taken with food (at least 350 calories) for proper absorption.\n\nDosage may vary depending on the individual’s medical condition, age, and treatment response.\n\nNever change the dosage or stop the medication without consulting a mental health professional.\n\nConsistency is crucial—take the tablet at the same time each day to maintain stable medication levels in the body.\n\nIf a dose is missed, take it as soon as possible unless it is close to the next scheduled dose.\n\nSide Effects\n\nLURASINODE 80 is generally well-tolerated, but some individuals may experience side effects. Common side effects include:\n\nDrowsiness or sleepiness\n\nNausea or stomach discomfort\n\nRestlessness or mild agitation\n\nDizziness or fatigue\n\nWeight fluctuations\n\nTremors or muscle stiffness\n\nDifficulty sleeping\n\nMore severe but rare side effects may include involuntary muscle movements, irregular heartbeat, severe mood changes, or allergic reactions. Seek immediate medical help if any serious symptoms occur.\n\nPrecautions and Warnings\n\nNot recommended for use during pregnancy or breastfeeding unless advised by a healthcare provider.\n\nIndividuals with a history of heart problems, seizures, diabetes, or liver disease must inform their doctor before starting the medication.\n\nAvoid alcohol, as it may increase drowsiness and interfere with mental alertness.\n\nThis medication may cause dizziness—avoid driving or operating heavy machinery until you know how it affects you.\n\nElderly patients with dementia-related psychosis should not use Lurasidone due to increased risk of adverse effects.\n\nDo not abruptly stop the medication; sudden withdrawal may worsen symptoms or cause relapse.\n\nStore in a cool, dry place and keep out of reach of children.\n\nConclusion\n\nLURASINODE 80, powered by Lurasidone Hydrochloride 80 mg, is a dependable and effective antipsychotic designed to treat schizophrenia and bipolar depression with strong, long-lasting therapeutic benefits. Its unique ability to balance neurotransmitters while minimizing metabolic side effects makes it a preferred choice for long-term mental health management. By improving emotional stability, reducing psychotic symptoms, and enhancing cognitive function, LURASINODE 80 empowers patients to regain control over their daily lives. When taken under proper medical supervision, it provides a safe, reliable path toward mental clarity and well-being.", "price": 410.0, "discountamount": 123.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2212, "imageuri": "https://productimages.withfloats.com/actual/691b1c6287483ff25f84ee39.png", "tileimageuri": "https://productimages.withfloats.com/tile/691b1c6287483ff25f84ee39.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-17T13:00:16.661Z", "updatedon": "2026-05-20T11:48:50.222Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//lurasidone-hydrochloride-80-mg-lurasinode-80/2212", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": " LURASINODE 80", "category": "NEUROLOGYRANGE", "tags": [ "Hydrochloride 80 mg", "LURASINODE 80", "mental health disorders", "balancing neurotransmitters in the brain", "helps improve mood, reduce hallucinations, and restore clear thinking", "mental health challenges", "This helps improve mood.", "This helps improve mood, reduce hallucinations, and restore clear thinking.", "Consistency is crucial.", "Schizophrenia.", "Bipolar Depression.", "Long-Term Symptom Management.", "Effective Control of Psychotic Symptoms.", "Improved Mood Stability.", "Supports Better Quality of Life." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662e74687f0960e14a2d95a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gefitinib 250mg", "description": "\n\nGEFISTERIS 250 is a premium pharmaceutical formulation containing Gefitinib 250mg, a breakthrough targeted therapy medication manufactured by Steris Healthcare. This innovative oral medication represents a significant advancement in the treatment of non-small cell lung cancer (NSCLC), offering patients a precise, scientifically-designed approach to combating one of the world's most challenging malignancies. GEFISTERIS 250 is specifically engineered to target the underlying molecular mechanisms that drive certain types of lung cancer, providing hope and extended survival for patients who carry specific genetic mutations.\nAs a tyrosine kinase inhibitor, GEFISTERIS 250 works at the cellular level to interrupt the signals that tell cancer cells to grow and divide. This targeted approach differs fundamentally from traditional chemotherapy, which affects both healthy and cancerous cells. By focusing specifically on cancer cells with epidermal growth factor receptor (EGFR) mutations, GEFISTERIS 250 offers a more refined treatment strategy with potentially fewer systemic side effects and improved quality of life during treatment.\nUnderstanding Gefitinib 250mg: The Science Behind GEFISTERIS 250\nGefitinib 250mg, the active pharmaceutical ingredient in GEFISTERIS 250, belongs to a revolutionary class of medications known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The development of this medication marked a paradigm shift in oncology, moving from one-size-fits-all chemotherapy approaches to personalized, mutation-specific treatments.\nThe EGFR protein is found on the surface of cells and plays a crucial role in cell growth and division. In normal cells, EGFR activation is carefully regulated. However, in certain lung cancers, mutations in the EGFR gene cause the receptor to remain constantly active, sending continuous signals for the cell to grow, divide, and survive—leading to uncontrolled cancer growth. GEFISTERIS 250 works by blocking the tyrosine kinase activity of the mutated EGFR protein, effectively turning off the growth signal and causing cancer cells to stop proliferating and eventually die.\nThis precision targeting is what makes GEFISTERIS 250 particularly effective for patients whose tumors harbor activating EGFR mutations, particularly the common exon 19 deletions or exon 21 L858R substitution mutations. Before initiating treatment with GEFISTERIS 250, patients undergo molecular testing to confirm the presence of these mutations, ensuring that the therapy is appropriately matched to their specific cancer biology.\nPrimary Uses and Indications of GEFISTERIS 250\nGEFISTERIS 250 is primarily indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors have specific EGFR mutations. The medication is approved for both first-line treatment in newly diagnosed patients and for those whose disease has progressed after platinum-based chemotherapy.\nFirst-Line Treatment: When EGFR mutations are detected in treatment-naïve patients, GEFISTERIS 250 offers an excellent first-line option, often providing superior progression-free survival compared to traditional chemotherapy regimens. Patients starting with targeted therapy typically experience better tolerability and quality of life during initial treatment phases.\nSecond-Line and Beyond: For patients whose cancer has progressed after chemotherapy, GEFISTERIS 250 provides an effective alternative treatment option, particularly when EGFR mutation testing was not performed initially or when the mutation status was unknown at the time of first treatment.\nThe medication is taken orally as a once-daily tablet, offering significant convenience compared to intravenous chemotherapy that requires hospital visits and lengthy infusion times. This oral administration allows patients to maintain greater independence and normalcy in their daily lives while receiving effective cancer treatment.\nKey Benefits of GEFISTERIS 250\n1. Targeted Cancer Fighting Action\nThe primary benefit of GEFISTERIS 250 lies in its precision targeting mechanism. Unlike conventional chemotherapy that attacks all rapidly dividing cells in the body, GEFISTERIS 250 specifically targets cancer cells bearing EGFR mutations. This selective action means that healthy cells are largely spared, resulting in a more favorable side effect profile and better preservation of normal bodily functions during treatment.\n2. Superior Efficacy in EGFR-Mutant NSCLC\nClinical trials have consistently demonstrated that GEFISTERIS 250 and other EGFR-TKIs provide superior progression-free survival compared to chemotherapy in patients with EGFR-mutant NSCLC. Response rates typically range from 60-80% in appropriate patient populations, with many patients experiencing significant tumor shrinkage and symptomatic improvement within weeks of starting treatment.\n3. Improved Quality of Life\nPatients taking GEFISTERIS 250 often report better quality of life compared to those receiving traditional chemotherapy. The medication's targeted nature results in fewer debilitating side effects such as severe nausea, hair loss, and profound fatigue. Many patients can continue working, traveling, and engaging in normal daily activities while on treatment.\n4. Convenient Oral Administration\nGEFISTERIS 250's once-daily oral dosing eliminates the need for frequent hospital visits for intravenous chemotherapy infusions. Patients take one tablet daily at home, providing tremendous convenience and reducing the burden of treatment. This ease of administration contributes significantly to treatment adherence and patient satisfaction.\n5. Rapid Symptom Relief\nMany patients experience rapid improvement in cancer-related symptoms such as cough, shortness of breath, chest pain, and fatigue within the first few weeks of GEFISTERIS 250 treatment. This quick symptomatic relief can dramatically improve quality of life even before significant tumor shrinkage is visible on imaging studies.\n6. Extended Survival Benefits\nLong-term data demonstrates that appropriate use of EGFR-TKIs like GEFISTERIS 250 contributes to extended overall survival in patients with EGFR-mutant lung cancer. When used as part of a comprehensive treatment strategy, including potential sequential therapies after progression, patients can achieve survival times that were unimaginable before the advent of targeted therapies.\n7. Manageable Side Effect Profile\nWhile GEFISTERIS 250 does cause side effects, they are generally more manageable than those associated with traditional chemotherapy. Most side effects can be effectively controlled with supportive medications, dose modifications, or temporary treatment interruptions, allowing patients to continue benefiting from therapy.\n8. Quality Manufacturing by Steris Healthcare\nGEFISTERIS 250 benefits from Steris Healthcare's commitment to pharmaceutical excellence. Each tablet undergoes rigorous quality testing to ensure consistent potency, purity, and bioavailability. This quality assurance means patients receive reliable, effective medication with every dose.\nSide Effects of GEFISTERIS 250 (Gefitinib 250mg)\nWhile GEFISTERIS 250 offers significant therapeutic benefits, patients should be aware of potential side effects. Understanding these effects enables early recognition and appropriate management.\nCommon Side Effects (Affecting 20% or More of Patients):\nSkin Reactions: The most characteristic side effect of GEFISTERIS 250 is an acne-like rash, typically appearing on the face, chest, and back within the first few weeks of treatment. This rash, while cosmetically concerning for some patients, actually correlates with better treatment response. The rash can be managed with topical antibiotics, moisturizers, and sun protection. In severe cases, temporary dose reduction may be necessary.\nDiarrhea: Approximately 50-60% of patients experience diarrhea of varying severity. Mild diarrhea can often be managed with dietary modifications and over-the-counter anti-diarrheal medications like loperamide. Patients should stay well-hydrated and contact their healthcare provider if diarrhea becomes severe or persistent, as dose adjustments may be needed.\nNail Changes: Some patients develop paronychia (nail bed inflammation) or other nail abnormalities. Proper nail care, avoiding trauma to the nail beds, and wearing protective gloves during housework can help minimize these effects.\nDry Skin: Many patients experience skin dryness and itching. Regular use of fragrance-free moisturizers, gentle cleansers, and avoidance of hot showers can help manage these symptoms.\nMouth Sores: Oral mucositis or stomatitis can develop in some patients. Good oral hygiene, avoiding spicy or acidic foods, and using alcohol-free mouthwashes can provide relief.\nLess Common but Serious Side Effects:\nInterstitial Lung Disease (ILD): While rare (1-2% of patients), ILD is the most serious potential side effect of GEFISTERIS 250. Symptoms include sudden onset or worsening of respiratory symptoms such as difficulty breathing, cough, or fever. This requires immediate medical attention and usually necessitates permanent discontinuation of the medication.\nLiver Function Abnormalities: Elevated liver enzymes can occur, requiring regular monitoring through blood tests. Most cases are asymptomatic and reversible with dose modification or temporary discontinuation.\nEye Problems: Dry eyes, corneal erosion, or other ocular issues may develop. Regular use of lubricating eye drops and ophthalmological evaluation when symptoms occur can prevent serious complications.\nGastrointestinal Perforation: Though rare, serious gastrointestinal complications including perforation can occur, particularly in patients with underlying GI conditions.\nManagement Strategies:\nMost side effects can be effectively managed through:\n\nProactive supportive care and prophylactic measures\nDose modifications (reduction to 250mg every other day in some cases)\nTemporary treatment interruptions allowing recovery\nSymptomatic treatment with appropriate medications\nPatient education about early recognition and reporting of symptoms\n\nPatients should maintain open communication with their healthcare team, reporting any new or worsening symptoms promptly. Regular monitoring through clinical visits and laboratory testing helps identify and address side effects before they become serious.\nDosage and Administration Guidelines\nThe standard dose of GEFISTERIS 250 is one 250mg tablet taken orally once daily, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. If a dose is missed and it's been less than 12 hours since the scheduled time, patients should take the missed dose. If more than 12 hours have passed, skip the missed dose and resume the regular schedule—never double up on doses.\nTreatment continues until disease progression or unacceptable toxicity occurs. Some patients remain on GEFISTERIS 250 for months or even years if they continue to benefit without prohibitive side effects. Dose modifications may be necessary based on individual tolerance, typically reducing the frequency to every other day rather than lowering the individual dose.\nPrecautions and Important Considerations\nPatients taking GEFISTERIS 250 should be aware of several important precautions. The medication can cause harm to developing fetuses, so women of childbearing potential must use effective contraception during treatment and for at least two weeks after the last dose. Breastfeeding should be avoided during treatment and for two weeks after completion.\nGEFISTERIS 250 can interact with medications that affect stomach acid, including proton pump inhibitors and H2-receptor antagonists. If antacids are needed, they should be taken several hours apart from GEFISTERIS 250. The medication may also interact with certain other drugs metabolized by the liver, so patients should inform their healthcare provider about all medications, supplements, and herbal products they're taking.\nRegular monitoring is essential during GEFISTERIS 250 treatment, including periodic liver function tests, pulmonary symptom assessment, and clinical evaluation for skin and other toxicities. Patients should avoid prolonged sun exposure and use high-SPF sunscreen, as the medication can increase photosensitivity.\nConclusion\nGEFISTERIS 250 represents a transformative treatment option for patients with EGFR-mutant non-small cell lung cancer, offering targeted, effective therapy with a manageable side effect profile. Manufactured by Steris Healthcare with unwavering commitment to quality and patient outcomes, GEFISTERIS 250 delivers Gefitinib 250mg in a formulation designed for optimal bioavailability and consistent therapeutic effect.\nThe medication's precision targeting of cancer-driving mutations, combined with convenient oral administration and generally tolerable side effects, makes GEFISTERIS 250 an excellent choice for eligible patients. While side effects do occur and require monitoring and management, the potential benefits—including tumor response, symptom improvement, extended progression-free survival, and enhanced quality of life—often significantly outweigh the risks for appropriately selected patients.\nSuccess with GEFISTERIS 250 requires partnership between patients and their healthcare teams. Molecular testing to confirm EGFR mutation status before treatment, adherence to the prescribed regimen, proactive management of side effects, and regular monitoring all contribute to optimal outcomes. For many patients with EGFR-mutant lung cancer, GEFISTERIS 250 offers not just treatment, but genuine hope for extended, quality life.\nAs personalized medicine continues to evolve, medications like GEFISTERIS 250 exemplify the power of matching treatments to individual tumor characteristics. Steris Healthcare's commitment to delivering this advanced therapy with assured quality and accessibility ensures that more patients can benefit from the remarkable advances in targeted cancer treatment that Gefitinib 250mg represents.\n", "price": 2760.0, "discountamount": 828.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "Call", "Uses", "Rash", "Note", "NSCLC", "Email", "nausea", "Dosage", "spread", "WhatsApp", "diarrhea", "Gefitinib", "treatment", "One tablet", "GEFISTERIS", "information", "sterispharma", "consultation", "sterisonline", "Side Effects", "cancer cells", "targeted therapy", "Regular monitoring", "healthcare provider", "small cell lung cancer", "healthcare professional", "specific EGFR mutations", "epidermal growth factor receptor", "potential liver function alterations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1530, "imageuri": "https://productimages.withfloats.com/actual/667d25ffb56721898510e93e.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d25ffb56721898510e93e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:56:06.808Z", "updatedon": "2026-04-15T10:04:00.767Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gefitinib-250mg/1530", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GEFISTERIS 250", "category": "Oncology", "tags": [ "gefitinib 250 mg uses", "gefitinib 250 mg online purchase", "gefitinib 250 mg tablets price in india", "non-small cell lung cancer (NSCLC).", "triggered by chemotherapy.", "cancer biology.", "Superior Efficacy in EGFR-Mutant NSCLC", "gefitinib 250mg", "gefitinib 250mg tablet", "gefitinib 250mg tab", "gefitinib 250 mg tablet uses in lung cancer", "gefitinib tablets 250 mg dosage and benefits", "gefitinib 250 mg price in india", "gefitinib 250 mg EGFR inhibitor for NSCLC treatment india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }